Cornea

Skip Navigation LinksHome > August 2011 - Volume 30 - Issue 8 > The Comparison of the Effects of Latanoprost, Travoprost, an...
Cornea:
doi: 10.1097/ICO.0b013e3182000c27
Clinical Science

The Comparison of the Effects of Latanoprost, Travoprost, and Bimatoprost on Central Corneal Thickness

Zhong, Yisheng MD; Shen, Xi MD; Yu, Jun MS; Tan, Haibo MS; Cheng, Yu MS

Collapse Box

Abstract

Purpose: To compare the effects of latanoprost, travoprost, and bimatoprost on central corneal thickness (CCT).

Methods: A total of 69 eyes of 69 patients with glaucoma or ocular hypertension submitted to monotherapy with prostaglandin analogues (latanoprost 0.005%, travoprost 0.004%, or bimatoprost 0.03%) during a mean of 17.19 ± 15.71 months follow-up period. Measurements were performed at the initial diagnosis and at the end of follow-up. All the measurements were carried out by the same doctor between 9 am and 11 am, using Goldmann applanation tonometer for intraocular pressure and ultrasonic pachymetry for CCT.

Results: A statistically significant reduction in CCT was observed in all groups (P < 0.001). The reduction of CCT in the latanoprost, travoprost, and bimatoprost groups was 14.95 ± 5.04, 15.73 ± 3.25, and 17.00 ± 6.23 μm, respectively. No significant difference was found in the reduction of CCT among the 3 groups (P > 0.05). No significant difference was also found in the reduction of CCT between the patients with less than or equal to 6 months' treatment and the patients with more than 6 months' treatment in the 3 groups (P > 0.05).

Conclusions: Topical therapy with prostaglandin analogues is associated with CCT reduction. Latanoprost, travoprost, and bimatoprost have a similar effect on CCT.

© 2011 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.